Oncology
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists at one Virginia practice have now been named to a regional hall of fame for physicians — but the real…
-
Montreal researchers identify molecular mechanism that sabotages cancer immunotherapy
MONTREAL — For a significant number of cancer patients, the most advanced immunotherapies simply stop working. Tumors that initially shrink eventually grow…
-
Johann Lafer Says Lymphoma Cannot Be Cured After Early Chemotherapy Gains Shrank His Lymph Nodes
Understanding Lafer’s Condition Lafer was diagnosed with an indolent, low-grade, non-Hodgkin lymphoma earlier this year, with the diagnosis being made public in…
-
Montreal researchers discover SLAMF6 molecule directly shuts down immune cell defenses
MONTREAL — The molecule that shuts down the body’s cancer defenses does not need a middleman. It acts on its own. That…
-
Montreal team finds SLAMF6 immune brake that may explain cancer drug resistance
MONTREAL — Scientists at the Montreal Clinical Research Institute (IRCM) have identified a previously unknown immune-suppressing mechanism that may explain why some…
-
Cancer Cells Hiding From Killer T Cells Become Targets for Helper T Cells
For decades, the prevailing view in oncology held that cancer cells that lose MHC class I molecules become invisible to cytotoxic CD8⁺…
-
Study Reveals Hidden Tumors May Be More Vulnerable to Immune Attack
Michigan, June 6, 2026 — cybernewschronicle.com — Cancer cells that go invisible to the immune system might have just painted a target…
-
Keytruda in Cancer Care: How Pembrolizumab Works and Which Side Effects to Watch
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
FDA Approves Lazertinib With Amivantamab as First-Line Treatment for EGFR Lung Cancer
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
Moderna’s KRAS Cancer Vaccine Candidate Was Dropped by Merck After Phase 1 Enrollment
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
Talquetamab Wins FDA Accelerated Approval, Then European Approval, for Relapsed Multiple Myeloma
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
City of Hope Drug AOH1996 Moves Through Early Human Trial After Mouse Study Results
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
-
FDA Grants Accelerated Approval to Elrexfio for Heavily Treated Multiple Myeloma
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
FDA Approves Adstiladrin, First Gene Therapy for BCG-Unresponsive Bladder Cancer
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992